Telix Pharmaceuticals Limited announced the establishment Telix Pharmaceuticals (Japan) Ltd. ("Telix Japan"). Telix Japan is wholly-owned operating subsidiary of the company. The purpose of the subsidiary is to support the Company's Japanese clinical and radiopharmaceutical manufacturing activities and to establish a commercial footprint in the Japan, an important market for Telix's products.

The company also announced appointment of the first two members of the Japanese leadership team. To lead the Telix Japan activities, Dr. Shintaro Nishimura and Dr. Takeshi Oka have been appointed as President and Chief Operating Officer, and Chief Medical Officer (Japan), respectively.